Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2016-11-28 15:42:53
Reporting Period:
Filing Date:
Accepted Time:
2016-11-28 15:42:53
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1434316 Fate Therapeutics Inc FATE () 4
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1376043 P Timothy Coughlin C/o Fate Therapeutics, Inc.;
3535 General Atomics Court, Suite 200
San Diego CA 92121
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-11-23 56,390 $2.66 56,390 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
  1. Represents shares acquired in a private placement pursuant to the Securities Purchase Agreement dated November 21, 2016 by and among the issuer and the purchasers named therein.